# MIRVASO
> **NDA204708** · New Drug Application · Sponsor: GALDERMA LABS LP · Approved 2013-08-23
## Drug
- **FDA Application Number:** NDA204708
- **Application type:** New Drug Application
- **Brand name:** MIRVASO
- **Generic name:** BRIMONIDINE TARTRATE
- **Active ingredients:** BRIMONIDINE TARTRATE
- **Dosage form:** GEL
- **Route:** TOPICAL
- **Marketing status:** Prescription
- **Sponsor:** GALDERMA LABS LP
- **Manufacturer:** Galderma Laboratories, L.P.
- **First approval:** 2013-08-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204708)
---
*AI Analytics · CC0 1.0*